Detalhe da pesquisa
1.
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
N Engl J Med
; 389(2): 148-157, 2023 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272527
2.
Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5).
Blood
; 143(6): 496-506, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879047
3.
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
Blood
; 141(6): 567-578, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399715
4.
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma.
Blood
; 140(21): 2248-2260, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839452
5.
Primary Cutaneous Gamma-Delta T-Cell Lymphoma Mimicking anaplastic lymphoma kinase-1-Negative Anaplastic Large Cell Lymphoma: A Case Report.
Am J Dermatopathol
; 44(1): 62-65, 2022 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34889814
6.
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.
Cancer
; 127(4): 609-618, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33085090
7.
Cutaneous T-cell lymphoma in sub-Saharan Africa.
J Natl Compr Canc Netw
; 11(3): 275-280, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23486453
8.
Myeloid/lymphoid neoplasm with ZMYM2::FGFR1 rearrangement: A complex trilineage phenotypic and clonal evolution with associated genomic alterations.
Leuk Res Rep
; 19: 100370, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37275466
9.
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma.
Clin Cancer Res
; 29(10): 1894-1905, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999993
10.
Gemcitabine and docetaxel as a novel treatment regimen for blastic plasmacytoid dendritic cell neoplasm.
Am J Hematol
; 92(5): E75-E77, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28224664
11.
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial.
Nat Med
; 28(4): 735-742, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35314842
12.
Pembrolizumab-Associated Seronegative Myasthenia Gravis in a Patient With Metastatic Renal Cell Carcinoma.
Cureus
; 13(5): e15174, 2021 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34178496
13.
Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience.
Biol Blood Marrow Transplant
; 15(11): 1447-54, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19822305
14.
Neurological manifestations of Waldenström macroglobulinemia.
Nat Clin Pract Neurol
; 4(10): 547-56, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18813229
15.
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis.
Blood Adv
; 2(8): 933-940, 2018 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29685953
16.
Maintenance eculizumab dose adjustment in the treatment of atypical hemolytic uremic syndrome: a case report and review of the literature.
Clin Case Rep
; 4(8): 773-6, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27525082
17.
Epidemiology, Diagnosis, and Treatment of HIV-Associated Non-Hodgkin Lymphoma in Resource-Limited Settings.
Adv Hematol
; 2012: 932658, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22548067